Habibi Soola, Aghil https://orcid.org/0000-0003-0957-3430
Mozaffari, Naser https://orcid.org/0000-0002-1895-5257
Hashemian Moghadam, Azam https://orcid.org/0000-0001-8505-4283
Hashemian, Maryam https://orcid.org/0000-0002-2852-2615
Saeedyan, Masoud https://orcid.org/0000-0002-2712-6039
Mirzaei, Alireza https://orcid.org/0000-0003-4242-2108
Article History
Received: 11 August 2025
Accepted: 24 November 2025
First Online: 5 December 2025
Declarations
:
: The study was approved by the Ethics Committee of Ardabil University of Medical Sciences (IR.ARUMS.REC.1401.156) and obtained written informed consent from all participants. It follows the Declaration of Helsinki and relevant national laws regarding research with human participants, ensuring voluntary participation and the right to withdraw at any time without penalty. There are strict confidentiality measures, minimized risks, and special protections for vulnerable populations. The study includes a clear benefit-risk assessment, ongoing safety monitoring, and accessible reporting for adverse events. Additionally, it maintains transparency in data handling and manages potential conflicts of interest, with provisions for reproducibility and data sharing upon request.
: Not applicable.
: The authors declare no competing interests.